These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1672276

  • 21. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
    Chapman AG, Cheetham SC, Hart GP, Meldrum BS, Westerberg E.
    J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
    [Abstract] [Full Text] [Related]

  • 22. One to three day dose intervals during subchronic treatment of epileptic gerbils with gamma-vinyl GABA: anticonvulsant efficacy and alterations in regional brain GABA levels.
    Löscher W, Frey HH.
    Eur J Pharmacol; 1987 Nov 17; 143(3):335-42. PubMed ID: 3691661
    [Abstract] [Full Text] [Related]

  • 23. Regulation of transmitter gamma-aminobutyric acid (GABA) synthesis and metabolism illustrated by the effect of gamma-vinyl GABA and hypoglycemia.
    Paulsen RE, Fonnum F.
    J Neurochem; 1988 Apr 17; 50(4):1151-7. PubMed ID: 2894410
    [Abstract] [Full Text] [Related]

  • 24. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkanen A.
    Br J Clin Pharmacol; 1989 Apr 17; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [Abstract] [Full Text] [Related]

  • 25. Effects of gamma-vinyl GABA (vigabatrin) on blood pressure and body weight of hypertensive and normotensive rats.
    Singewald N, Pfitscher A, Philippu A.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb 17; 345(2):181-6. PubMed ID: 1570022
    [Abstract] [Full Text] [Related]

  • 26. Nuclear magnetic resonance detection of increased cortical GABA in vigabatrin-treated rats in vivo.
    Preece NE, Jackson GD, Houseman JA, Duncan JS, Williams SR.
    Epilepsia; 1994 Feb 17; 35(2):431-6. PubMed ID: 8156969
    [Abstract] [Full Text] [Related]

  • 27. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L.
    Acta Neurol Scand; 1988 Oct 17; 78(4):241-70. PubMed ID: 3146860
    [Abstract] [Full Text] [Related]

  • 28. Effect of gamma-vinyl GABA treatment on cholinergic and aminergic neurotransmission and on cyclic nucleotides in human complex partial epilepsy--a CSF study.
    Riekkinen PJ, Pitkänen A, Halonen T, Lehtinen M, Ylinen A, Sivenius J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Oct 17; 12(1):81-91. PubMed ID: 2452456
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Potentiation of gamma-vinyl GABA (vigabatrin) effects by glycine.
    Liu Z, Seiler N, Marescaux C, Depaulis A, Vergnes M.
    Eur J Pharmacol; 1990 Jun 21; 182(1):109-15. PubMed ID: 2119308
    [Abstract] [Full Text] [Related]

  • 35. Changes in CSF and brain soluble proteins following vigabatrin treatment in rats.
    Persson LI, Rönnbäck L, Ben-Menachem E, Eriksson P, Nilsson M.
    Br J Clin Pharmacol; 1989 Jun 21; 27 Suppl 1(Suppl 1):73S-77S. PubMed ID: 2757913
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of gamma-vinyl-GABA on the human electroencephalogram.
    Hammond EJ, Wilder BJ.
    Neuropharmacology; 1985 Oct 21; 24(10):975-84. PubMed ID: 2999635
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from gamma-vinyl GABA (vigabatrin)-pretreated rats.
    Jackson MF, Esplin B, Capek R.
    Neuropharmacology; 2000 Oct 21; 39(1):65-74. PubMed ID: 10665820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.